glp-1 agonist drugs oral Comparing Ozempic, Wegovy and Other GLP-1 receptor agonist - Diabetes

There are a large number of studies that have reported the application of exendin-4, liraglutide and exenatide in the treatment of cognitive dysfunction and pathological features in AD models

The CVOT results for the oral version of semaglutide (Rybelsus) are pending, with results expected soon

PMID: 21454562

Zhou QX, Wang ZY, Zhao HF, Wang S

The use of incretin mimetics is also recommended as add-on therapy in people with type 2 diabetes and obesity when initial therapy provides insufficient glycaemic control.

The potential of the emerging Glucagon-like Peptide-1 (GLP-1) Agonists in changing the current clinical practice guidelines is crucial to analyze, especially when it comes to real-world scenarios